Could the defects in the endometrial extracellular matrix during the implantation be a cause for impaired fertility?

American Journal of Reproductive Immunology

Volumn 57, Issue 1, 2007, Pages 40-48

  Skrzypczak, Jana ^a   Wirstlein, Przemysław ^a   Mikolajczyk, Mateusz ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Division of Reproduction   (Poland)

Author keywords

Infertility; Metalloproteinase 9; Miscarriage; Tissue inhibitor of metalloproteinases 1; Uterine fluid

Indexed keywords

GELATINASE B; LEUKEMIA INHIBITORY FACTOR; PROGESTERONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UROKINASE; UROKINASE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FEMALE INFERTILITY; HUMAN; NIDATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN METABOLISM; RECURRENT DISEASE; SPONTANEOUS ABORTION; TURNOVER TIME; UTERUS FLUID;

ABORTION, HABITUAL; ADULT; EMBRYO IMPLANTATION; ENDOMETRIUM; EXTRACELLULAR MATRIX; FEMALE; FERTILITY; HUMANS; LEUKEMIA INHIBITORY FACTOR; METALLOPROTEASES; PREGNANCY; PROGESTERONE; RECEPTORS, CELL SURFACE;

EID: 33845476286     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00443.x     Document Type: Article

References (28)

1. Li TC, Dockery P, Cooke ID: Endometrial development in the luteal phase of woman with various types of infertility: Comparison with women of normal fertility. Hum Reprod 1991; 6: 325-330.
2. Serle E, Aplin JD, Li TC, Warren MA, Graham RA, Seif MW, Cooke ID: Endometrial differentiation in the peri-implantation phase of women with recurrent miscarriage: A morphological and immunohistochemical study. Fertil Steril 1994; 62: 989-996.
3. Tabibzadeh S: Molecular control of the implantation window. Hum Reprod Update 1998; 4: 465-471.
4. Jeziorska M, Nagase H, Salamonsen LA, Wooley DE: Immunolocalization of the matrix metalloproteinases, gelatinase B and stromielysin-1 in human endometrium thought the menstrual cycle. J Reprod Fertil 1996; 107: 43-51.
5. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG: Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994; 94: 946-953.
6. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P: Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulator mechanism with cell-bound reactants. EMBO J 1997; 16: 2319-2332.
7. Bischof P, Haenggeli L, Campana A: Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. Am J Reprod Immunol 1995; 34: 225-230.
8. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378: 151-160.
9. Salamonsen LA, Wooley DE: Matrix metalloproteinases and menstruation. Hum Reprod 1996; 11: 124-133.
10. Wu RJ, Zhon FI: Expression of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinases-1 mRNA in the endometrium during mid-luted phase in women with unexplained infertility. Zhonghua Fu Chan Ke Za Zhi 2003; 6: 346-349 (abstract).
11. Irwin JC, Krik D, Ralph B, Gwatkin RBL, Navare M, Cannon P, Guidice LC: Human endometrial matrix metalloproteinases-2, a putative menstrual proteinase. Hormonal regulation in cultures stromal cells and mRNA expression during the menstrual cycle. J Clin Invest 1996; 97: 438-447.
12. Salamonsen LA, But AR, Hammond FR, Gracia S, Zhang J: Production of endometrial matrix metalloproteinases but not their tissue inhibitors is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 1997; 82: 1409-1415.
13. Zhang J, Salamonsen LA: In vitro evidence active matrix metalloproteinase in human endometrium supports their role in tissue breakdown at menstruation. J Clin Endocrinol Metab 2002; 87: 52346-52351.
14. Freitas S, Meduri G, Nestour E, Bausero P, Applant M: Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod 1999; 61: 1070-1082.
15. Inagaki N, Stern C, McBain J, Lopata A, Kornman L, Wilkinson D: Analysis of intra-uterine cytokine concentration and matrix-metalloproteinase activity in women with recurrent failed embryo transfer. Hum Reprod 2003; 18: 608-615.
16. Jokimaa V, Oksjoki S, Kujari H, Vuorio E, Antilla L: Altered expression of genes involved in the production and degradation of endometrial extracellular patients with unexplained infertility and recurrent miscarriages. Mol Hum Reprod 2002; 8: 1111-1116.
17. Mikołajczyk M, Wirstlein P, Szymanowski K, Skrzypczak J. In vivo correlation between IL-1β concentration in uterine fluid and integrin expression pattern in infertile women. Am J Reprod Immunol 2006; 55: 156-163.
18. Śliwowska I, Kopczyński Z: Metaloproteinazy macierzy zewntrzkomórkowej - charakterystyka biochemiczna i kliniczna wartości oznaczania u chorych na raka piersi. Współ Onkologia 2005; 9: 327-335.
19. Leppert D, Lindberg RL, Kappos L, Leib SL: Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001; 36: 249-257.
20. Yong VW, Power C, Forsyth P, Edwards DR: Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001; 2: 502-511.
21. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani NS, Hawkes SP, Werb Z: Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996; 122: 1723-1739.
22. Bany BM, Harvey MB, Schultz GA: Expression of matrix metalloproteinases 2 and 9 in the mouse uterus during implantation and oil-induced decidualization. J Reprod Fertil 2000; 120: 125-134.
23. Whiteside EJ, Jackson MM, Herington AC, Edwards D, Harvey MB: Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos. Biol Reprod 2001; 64: 1331-1337.
24. Dong-Mok L, Tae-Kyun L, Hai-Bum S, Cheorl-Ho K: The expression of matrix metalloproteinase-9 in human follicular fluid is associated with in vitro fertilization pregnancy. BJOG 2005; 112: 946-951.
25. Walentynowicz M, Grabiec M, Szymański W: Steżenie urokinazowego aktywatora plazminogenu (uPA), jego receptora (uPAR) i inhibitora aktywnego plazminogenu PAI w płynie pe;cherzykowym u pacjentek poddawanych kontrolowanej stymulacji jajników. Przeglad Gin Poł 2005; 5: 339-346.
26. Epifanio O, Raminucci M, Manna C, Apa R, Greco E, Lanzone A, Stefanini M, Canpari R: In vitro production of plasminogen activator by human granulosa cells. J Clin Endocrinol Metab 1994; 78: 174-179.
27. Charnock-Jones DS, Sharkey AM, Fenwick P, Smith SK: Leukemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 1994; 101: 421-426.
28. Ledee-Bataille N, Laparee-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G: Concentration of leukemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod 2002; 17: 213-218.